文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

双调蛋白对小鼠急性呼吸窘迫综合征的作用及机制

[Effect and mechanism of amphiregulin on acute respiratory distress syndrome in mice].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论小鼠实验中,双调蛋白经激活PI3K/AKT通路抑制肺泡上皮细胞凋亡,减轻LPS诱导的ARDS。

该研究为动物实验与细胞实验,探讨双调蛋白(Areg)对小鼠急性呼吸窘迫综合征(ARDS)的保护作用及机制。动物实验将6-8周龄雄性C57BL/6小鼠随机分为假手术组、ARDS模型组(气管内滴注LPS 3 mg/kg)和ARDS+Areg干预组(LPS造模后1小时腹腔注射重组小鼠Areg 5 μg),每组n=10,LPS注射后24小时处死;细胞实验用MLE12细胞系,设空白对照组、LPS组(1 mg/L)和LPS+Areg组(LPS刺激后1小时加rmAreg 50 μg/L)。结果显示Areg干预组肺损伤评分、氧合指数、肺湿/干重比及BALF蛋白和炎症因子水平均较ARDS模型组显著改善(均P<0.01);细胞实验中LPS+Areg组凋亡细胞数显著减少,p-PI3K/PI3K、p-AKT/AKT和Bcl-2表达显著升高,Bax表达显著抑制(均P<0.01)。作者结论认为Areg通过激活PI3K/AKT通路抑制肺泡上皮细胞凋亡而减轻小鼠ARDS。

要点

  • ARDS+Areg组肺损伤评分较ARDS模型组显著降低(0.467±0.031 vs. 0.690±0.034,P<0.01)。
  • ARDS+Areg组氧合指数较ARDS模型组显著升高(380.00±22.36 mmHg vs. 154.00±20.74 mmHg,P<0.01)。
  • ARDS+Areg组肺湿/干重比(5.40±0.26 vs. 6.63±0.25)及BALF蛋白(0.42±0.04 g/L vs. 0.86±0.05 g/L)均显著低于ARDS模型组(均P<0.01)。
  • ARDS+Areg组BALF中IL-1β(30.00±2.00 ng/L vs. 40.00±3.65 ng/L)、IL-6(190.00±20.30 ng/L vs. 581.30±45.76 ng/L)、TNF-α(30.00±3.65 ng/L vs. 77.00±4.16 ng/L)均显著低于ARDS模型组(均P<0.01)。
  • LPS+Areg组MLE12细胞凋亡率显著低于LPS组[(17.51±2.12)% vs.(36.35±2.84)%,P<0.01],p-PI3K/PI3K、p-AKT/AKT和Bcl-2/GAPDH显著升高,Bax/GAPDH显著降低(均P<0.01)。

适用人群与场景

  • 动物实验:6-8周龄雄性C57BL/6小鼠,随机分为假手术组、ARDS模型组、ARDS+Areg干预组,每组n=10。
  • 细胞实验:小鼠肺泡上皮细胞系MLE12细胞,设空白对照组、LPS组(1 mg/L)、LPS+Areg组(rmAreg 50 μg/L)。

诊断标准与关键阈值

  • 小鼠ARDS模型建立方法:气管内滴注脂多糖(LPS)3 mg/kg。

处置流程与药物剂量

  • ARDS+Areg干预组:LPS造模后1小时腹腔注射重组小鼠双调蛋白(rmAreg)5 μg。
  • 细胞LPS+Areg组:LPS刺激后1小时加入rmAreg 50 μg/L。
  • LPS注射后24小时处死小鼠,LPS刺激后24小时收集细胞及培养液进行检测。

研究设计与关键结果

  • 动物实验:与假手术组比较,ARDS模型组肺组织结构破坏、肺损伤评分显著升高、氧合指数显著降低、肺湿/干重比显著升高、BALF蛋白及炎症因子水平显著升高。
  • 与ARDS模型组比较,ARDS+Areg组肺组织结构损伤减轻,肺间质充血、水肿及炎症细胞浸润显著减少,肺损伤评分显著降低(0.467±0.031 vs. 0.690±0.034,P<0.01)。
  • ARDS+Areg组氧合指数显著高于ARDS模型组[380.00±22.36 mmHg vs. 154.00±20.74 mmHg,P<0.01;1 mmHg≈0.133 kPa]。
  • ARDS+Areg组肺湿/干重比(5.40±0.26 vs. 6.63±0.25)、BALF蛋白(0.42±0.04 g/L vs. 0.86±0.05 g/L)、IL-1β(30.00±2.00 ng/L vs. 40.00±3.65 ng/L)、IL-6(190.00±20.30 ng/L vs. 581.30±45.76 ng/L)、TNF-α(30.00±3.65 ng/L vs. 77.00±4.16 ng/L)均显著低于ARDS模型组(均P<0.01)。
  • 细胞实验:与空白对照组比较,LPS组MLE12细胞凋亡数显著增加,PI3K磷酸化水平、抗凋亡基因Bcl-2水平及促凋亡基因Bax水平均升高。
  • 与LPS组比较,LPS+Areg组MLE12细胞凋亡数显著减少[(17.51±2.12)% vs.(36.35±2.84)%,P<0.01],p-PI3K/PI3K(2.400±0.200 vs. 0.550±0.066)、p-AKT/AKT(1.647±0.103 vs. 0.573±0.101)、Bcl-2/GAPDH(0.773±0.061 vs. 0.343±0.071)显著升高,Bax/GAPDH显著降低(0.810±0.095 vs. 2.400±0.200),差异均有统计学意义(均P<0.01)。

证据类型、等级与局限

  • 证据类型:动物实验与细胞实验(小鼠ARDS模型及MLE12细胞系)。
  • 作者结论:Areg通过激活PI3K/AKT通路抑制肺泡上皮细胞凋亡,从而减轻小鼠ARDS。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠与细胞实验,提示双调蛋白可能通过激活PI3K/AKT通路抑制肺泡上皮细胞凋亡而减轻ARDS,作者结论认为Areg可减轻小鼠ARDS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the protective effect of amphiregulin (Areg) on acute respiratory distress syndrome (ARDS) in mice and its underlying mechanism.

METHODS: (1) Male C57BL/6 mice aged 6-8 weeks were selected for animal experiments and divided into 3 groups (n = 10) according to the random number table method, which includes sham-operated group (Sham group), ARDS model group [ARDS model in mice was established by intratracheal instillation of lipopolysaccharide (LPS) 3 mg/kg] and ARDS+Areg intervention group [recombinant mice Areg (rmAreg) 5 μg was injected intraperitoneally 1 hour after LPS modeling]. The mice were sacrificed at 24 h after LPS injection lung histopathological changes were observed under hematoxylin-eosin (HE) staining and scored for lung injury; oxygenation index and wet/dry ratio of lung tissue were measured; the content of protein in bronchoalveolar lavage fluid (BALF) was detected by bicinchoninic acid (BCA) method, the level of inflammatory factors interleukins (IL-1β, IL-6) and tumor necrosis factor-α (TNF-α) in BALF were measured by enzyme-linked immunosorbent assay (ELISA). (2) Mice alveolar epithelial cell line MLE12 cells were obtained and cultured for experiment in vitro. Blank control group (Control group), LPS group (LPS 1 mg/L) and LPS+Areg group (rmAreg 50 μg/L was added 1 hour after LPS stimulation) were set. The cells and culture fluid were collected at 24 hours after LPS stimulation, and the apoptosis level of MLE12 cells was detected by flow cytometry; the activation level of phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) and the expressions of apoptosis-related proteins Bcl-2 and Bax in MLE12 cells were detected by Western blotting.

RESULTS: (1) Animal experiments: compared with the Sham group, the lung tissue structure of ARDS model group was destroyed, the lung injury score was significantly increased, the oxygenation index was significantly decreased, the wet/dry weight ratio of lung was significantly increased, and the levels of protein and inflammatory factors in BALF were significantly increased. Compared with ARDS model group, lung tissue structure damage was reduced, pulmonary interstitial congestion, edema and inflammatory cell infiltration were significantly reduced, and lung injury score was significantly decreased (scores: 0.467±0.031 vs. 0.690±0.034) in ARDS+Areg intervention group. In addition, oxygenation index in ARDS+Areg intervention group was significantly increased [mmHg (1 mmHg ≈ 0.133 kPa): 380.00±22.36 vs. 154.00±20.74]. Lung wet/dry weight ratio (5.40±0.26 vs. 6.63±0.25), protein and inflammatory factors levels in BALF [protein (g/L): 0.42±0.04 vs. 0.86±0.05, IL-1β (ng/L): 30.00±2.00 vs. 40.00±3.65, IL-6 (ng/L): 190.00±20.30 vs. 581.30±45.76, TNF-α (ng/L): 30.00±3.65 vs. 77.00±4.16], and the differences were statistically significant (all P < 0.01). (2) Cell experiments: compared with the Control group, the number of apoptotic MLE12 cells was significantly increased in the LPS group, and the levels of PI3K phosphorylation, anti-apoptotic gene Bcl-2 level and pro-apoptotic gene Bax level were increased in MLE12 cells. Compared with the LPS group, the number of apoptosis in MLE12 cells was significantly reduced in the LPS+Areg group after administration of rmAreg treatment [(17.51±2.12)% vs. (36.35±2.84)%], and the levels of PI3K/AKT phosphorylation and Bcl-2 expression in MLE12 cells were significantly increased (p-PI3K/PI3K: 2.400±0.200 vs. 0.550±0.066, p-AKT/AKT: 1.647±0.103 vs. 0.573±0.101, Bcl-2/GAPDH: 0.773±0.061 vs. 0.343±0.071), and Bax expression was significantly suppressed (Bax/GAPDH: 0.810±0.095 vs. 2.400±0.200). The differences were statistically significant (all P < 0.01).

CONCLUSIONS: Areg could alleviate ARDS in mice by inhibiting the apoptosis of alveolar epithelial cells through activating PI3K/AKT pathway.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li Q, Yuan L, Yang Y, et al. [Effect and mechanism of amphiregulin on acute respiratory distress syndrome in mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308229. doi:10.3760/cma.j.cn121430-20220822-00767

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。